Prognostic Importance of Tumor Cells in Bone Marrow for Breast Cancer
Author Information
Author(s): Christian Schindlbeck, Theresa Kampik, Wolfgang Janni, Brigitte Rack, Udo Jeschke, Stan Krajewski, Harald Sommer, Klaus Friese
Primary Institution: Ludwig-Maximilians-University
Hypothesis
Which biological factors of primary breast tumors predict the presence of disseminated tumor cells in the bone marrow?
Conclusion
The presence of disseminated tumor cells in the bone marrow is a significant prognostic factor for overall survival in breast cancer patients.
Supporting Evidence
- 25.7% of patients showed disseminated tumor cells in bone marrow.
- HER2 positivity correlated with disease-free survival.
- Ki 67 positivity was significant for shortened disease-free survival.
Takeaway
This study found that some breast cancer patients have tumor cells in their bone marrow, which can help doctors understand how serious the cancer is and how to treat it better.
Methodology
The study analyzed tissue microarrays of 265 breast cancer patients for various biological factors and assessed bone marrow for disseminated tumor cells.
Potential Biases
Potential bias due to the retrospective nature and selection of patients.
Limitations
The study is retrospective and may not account for all variables affecting outcomes.
Participant Demographics
Median age of participants was 57 years, with 31% premenopausal and 69% postmenopausal.
Statistical Information
P-Value
p = 0.03
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website